Last 12 months
Inside the activity.
0 purchase rows · 27 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 7 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 10 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 02, 2021 Filed Dec 4, 2021 01:00 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,342 | $0.00 Strike: $13.62 | $0.00 |
DisclosureSEC source: 0001209191-21-068014 · doc4.xml · derivative · entry 2 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,632 Underlying: Common Shares · 7,342 shares Expires 2027-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option was granted on May 31, 2017 with respect to 123,000 Common Shares of which 25% vested on May 31, 2018 and the remaining 75% shall vest monthly thereafter for 36 months. Read SEC document |
| December 02, 2021 Filed Dec 4, 2021 01:00 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
Exercise / conversionCommon Shares | 7,342 | $13.62 | $99,998.04 |
DisclosureSEC source: 0001209191-21-068014 · doc4.xml · nonDerivative · entry 1 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,512 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2021 Filed Dec 4, 2021 01:00 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Tax withholdingCommon Shares | 779 | $75.10 | $58,502.90 |
DisclosureSEC source: 0001209191-21-068013 · doc4.xml · nonDerivative · entry 1 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,153 F1 · kind: On December 1, 2017, the reporting person was granted 26,667 restricted stock units. On December 1, 2021, 1,667 restricted stock units vested. Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 00:00 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
GrantStock Option (Right to Buy) · Derivative | 10,800 | $0.00 Strike: $97.00 | $0.00 |
DisclosureSEC source: 0001209191-21-060778 · doc4.xml · derivative · entry 1 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,800 Underlying: Common Shares · 10,800 shares Expires 2031-10-15 F1 · derivative.exercise_date: This option was granted on October 15, 2021 with respect to 10,800 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 15, 2021. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 00:00 UTC |
Klein Lawrence OttoCBO & COO
|
GrantStock Option (Right to Buy) · Derivative | 13,800 | $0.00 Strike: $97.00 | $0.00 |
DisclosureSEC source: 0001209191-21-060776 · doc4.xml · derivative · entry 1 Klein Lawrence Otto · CIK 0001762583 · CBO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,800 Underlying: Common Shares · 13,800 shares Expires 2031-10-15 F1 · derivative.exercise_date: This option was granted on October 15, 2021 with respect to 13,800 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 15, 2021. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 00:00 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 33,000 | $0.00 Strike: $1.81 | $0.00 |
DisclosureSEC source: 0001209191-21-060775 · doc4.xml · derivative · entry 3 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,983 Underlying: Common Shares · 33,000 shares Expires 2025-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted on September 10, 2015 with respect to 321,712 Common Shares with 120,640 of the shares vested on August 1, 2016, the first anniversary of employment commencement, and the remainder vested in equal 36 monthly installments thereafter. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 00:00 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 43,000 | $0.00 Strike: $97.00 | $0.00 |
DisclosureSEC source: 0001209191-21-060775 · doc4.xml · derivative · entry 2 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,000 Underlying: Common Shares · 43,000 shares Expires 2031-10-15 F1 · derivative.exercise_date: This option was granted on October 15, 2021 with respect to 43,000 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 15, 2021. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 00:00 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionCommon Shares | 33,000 | $1.81 | $59,730.00 |
DisclosureSEC source: 0001209191-21-060775 · doc4.xml · nonDerivative · entry 1 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,932 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 00:00 UTC |
Ho Tony WExecutive VP, Head of R&D
|
GrantStock Option (Right to Buy) · Derivative | 13,800 | $0.00 Strike: $97.00 | $0.00 |
DisclosureSEC source: 0001209191-21-060774 · doc4.xml · derivative · entry 1 Ho Tony W · CIK 0001713637 · Executive VP, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,800 Underlying: Common Shares · 13,800 shares Expires 2031-10-15 F1 · derivative.exercise_date: This option was granted on October 15, 2021 with respect to 13,800 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 15, 2021. Read SEC document |
| October 14, 2021 Filed Oct 19, 2021 00:00 UTC |
Smith BrendanChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 90,000 | $0.00 Strike: $98.70 | $0.00 |
DisclosureSEC source: 0001209191-21-060777 · doc4.xml · derivative · entry 2 Smith Brendan · CIK 0001857492 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Shares · 90,000 shares Expires 2031-10-14 F3 · derivative.exercise_date: This option was granted on October 14, 2021 with respect to 90,000 Common Shares, with 25% of the shares vesting on October 14, 2022 and the remaining shares vesting on each monthly anniversary thereafter for a period of 36 months. Read SEC document |
| October 14, 2021 Filed Oct 19, 2021 00:00 UTC |
Smith BrendanChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-060777 · doc4.xml · derivative · entry 1 Smith Brendan · CIK 0001857492 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Shares · 15,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F2 · derivative.exercise_date: This restricted stock unit award was granted on October 14, 2021 with respect to 15,000 Common Shares, with (i) one quarter of the shares vesting on October 14, 2022, (ii) one quarter of the shares vesting on October 14, 2023, (iii) one quarter of the shares vesting on October 14, 2024, and (iv) one quarter of the shares vesting on October 14, 2025. F2 · derivative.expiration_date: This restricted stock unit award was granted on October 14, 2021 with respect to 15,000 Common Shares, with (i) one quarter of the shares vesting on October 14, 2022, (ii) one quarter of the shares vesting on October 14, 2023, (iii) one quarter of the shares vesting on October 14, 2024, and (iv) one quarter of the shares vesting on October 14, 2025. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 01:45 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
Tax withholdingCommon Shares | 4,741 | $117.86 | $558,774.26 |
DisclosureSEC source: 0001209191-21-056093 · doc4.xml · nonDerivative · entry 2 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,170 F3 · kind: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 01:44 UTC |
Klein Lawrence OttoCBO & COO
|
Tax withholdingCommon Shares | 4,207 | $117.86 | $495,837.02 |
DisclosureSEC source: 0001209191-21-056092 · doc4.xml · nonDerivative · entry 2 Klein Lawrence Otto · CIK 0001762583 · CBO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,843 F3 · kind: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| September 10, 2021 Filed Sep 15, 2021 01:45 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
Disposition to issuerRestricted Stock Units · Derivative | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-056093 · doc4.xml · derivative · entry 3 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 10,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · derivative.exercise_date: The restricted stock unit award was granted on September 10, 2019 with respect to 10,000 Common Shares, with all shares vesting on September 10, 2021. F1 · derivative.expiration_date: The restricted stock unit award was granted on September 10, 2019 with respect to 10,000 Common Shares, with all shares vesting on September 10, 2021. Read SEC document |
| September 10, 2021 Filed Sep 15, 2021 01:45 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
Exercise / conversionCommon Shares | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-056093 · doc4.xml · nonDerivative · entry 1 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,911 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The restricted stock unit award was granted on September 10, 2019 with respect to 10,000 Common Shares, with all shares vesting on September 10, 2021. F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. Read SEC document |
| September 10, 2021 Filed Sep 15, 2021 01:44 UTC |
Klein Lawrence OttoCBO & COO
|
Tax withholdingRestricted Stock Units · Derivative | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-056092 · doc4.xml · derivative · entry 3 Klein Lawrence Otto · CIK 0001762583 · CBO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 10,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · derivative.exercise_date: The restricted stock unit award was granted on September 10, 2019 with respect to 10,000 Common Shares, with all shares vesting on September 10, 2021. F1 · derivative.expiration_date: The restricted stock unit award was granted on September 10, 2019 with respect to 10,000 Common Shares, with all shares vesting on September 10, 2021. Read SEC document |
| September 10, 2021 Filed Sep 15, 2021 01:44 UTC |
Klein Lawrence OttoCBO & COO
|
Exercise / conversionCommon Shares | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-056092 · doc4.xml · nonDerivative · entry 1 Klein Lawrence Otto · CIK 0001762583 · CBO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The restricted stock unit award was granted on September 10, 2019 with respect to 10,000 Common Shares, with all shares vesting on September 10, 2021. F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. Read SEC document |
| September 01, 2021 Filed Sep 4, 2021 00:00 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Tax withholdingCommon Shares | 787 | $124.83 | $98,241.21 |
DisclosureSEC source: 0001209191-21-054903 · doc4.xml · nonDerivative · entry 1 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,932 F1 · kind: On December 1, 2017, the reporting person was granted 26,667 restricted stock units. On September 1, 2021, 1,667 restricted stock units vested. Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| August 06, 2021 Filed Aug 11, 2021 00:00 UTC |
TOMSICEK MICHAEL JOHNChief Financial Officer
|
SaleCommon Shares | 5,989 | $139.46 | $835,225.94 |
DisclosureSEC source: 0001209191-21-050719 · doc4.xml · nonDerivative · entry 3 TOMSICEK MICHAEL JOHN · CIK 0001570392 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,891 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.06 to $139.69, inclusive. The reporting person undertakes to provide to CRISPR Therapeutics AG, any security holder of CRISPR Therapeutics AG, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 06, 2021 Filed Aug 11, 2021 00:00 UTC |
TOMSICEK MICHAEL JOHNChief Financial Officer
|
SaleCommon Shares | 19,011 | $138.22 | $2,627,700.42 |
DisclosureSEC source: 0001209191-21-050719 · doc4.xml · nonDerivative · entry 2 TOMSICEK MICHAEL JOHN · CIK 0001570392 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,880 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.00 to $138.97, inclusive. The reporting person undertakes to provide to CRISPR Therapeutics AG, any security holder of CRISPR Therapeutics AG, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 06, 2021 Filed Aug 11, 2021 00:00 UTC |
TOMSICEK MICHAEL JOHNChief Financial Officer
|
Exercise / conversionCommon Shares | 25,000 | $17.75 | $443,750.00 |
DisclosureSEC source: 0001209191-21-050719 · doc4.xml · nonDerivative · entry 1 TOMSICEK MICHAEL JOHN · CIK 0001570392 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2021 Filed Aug 7, 2021 00:00 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 28,500 | $0.00 Strike: $12.57 | $0.00 |
DisclosureSEC source: 0001209191-21-050256 · doc4.xml · derivative · entry 10 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,333 Underlying: Common Stock · 28,500 shares Expires 2026-07-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: This option was granted on July 15, 2016 with respect to 93,333 Common Shares with 100% of the shares vesting in 48 equal monthly installments beginning October 31, 2016. Read SEC document |
| August 05, 2021 Filed Aug 7, 2021 00:00 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
SaleCommon Stock | 2,482 | $130.51 | $323,925.82 |
DisclosureSEC source: 0001209191-21-050256 · doc4.xml · nonDerivative · entry 8 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,719 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.38 to $130.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 05, 2021 Filed Aug 7, 2021 00:00 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
SaleCommon Stock | 6,819 | $129.82 | $885,242.58 |
DisclosureSEC source: 0001209191-21-050256 · doc4.xml · nonDerivative · entry 7 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,201 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.38 to $130.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 05, 2021 Filed Aug 7, 2021 00:00 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
SaleCommon Stock | 13,499 | $128.85 | $1,739,346.15 |
DisclosureSEC source: 0001209191-21-050256 · doc4.xml · nonDerivative · entry 6 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,020 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.37 to $129.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 05, 2021 Filed Aug 7, 2021 00:00 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
SaleCommon Stock | 4,700 | $127.82 | $600,754.00 |
DisclosureSEC source: 0001209191-21-050256 · doc4.xml · nonDerivative · entry 5 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,519 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.37 to $128.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 05, 2021 Filed Aug 7, 2021 00:00 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
SaleCommon Stock | 1,000 | $126.67 | $126,670.00 |
DisclosureSEC source: 0001209191-21-050256 · doc4.xml · nonDerivative · entry 4 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,219 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.33 to $127.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 05, 2021 Filed Aug 7, 2021 00:00 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 28,500 | $12.57 | $358,245.00 |
DisclosureSEC source: 0001209191-21-050256 · doc4.xml · nonDerivative · entry 3 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 04, 2021 Filed Aug 7, 2021 00:00 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,500 | $0.00 Strike: $12.57 | $0.00 |
DisclosureSEC source: 0001209191-21-050256 · doc4.xml · derivative · entry 9 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,833 Underlying: Common Shares · 30,000 shares Expires 2026-07-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: This option was granted on July 15, 2016 with respect to 93,333 Common Shares with 100% of the shares vesting in 48 equal monthly installments beginning October 31, 2016. Read SEC document |
| August 04, 2021 Filed Aug 7, 2021 00:00 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
SaleCommon Shares | 1,500 | $125.02 | $187,530.00 |
DisclosureSEC source: 0001209191-21-050256 · doc4.xml · nonDerivative · entry 2 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,719 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.00 to $125.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 04, 2021 Filed Aug 7, 2021 00:00 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionCommon Shares | 1,500 | $12.57 | $18,855.00 |
DisclosureSEC source: 0001209191-21-050256 · doc4.xml · nonDerivative · entry 1 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 21:21 UTC |
Bolzon Bradley J PhDDirector
|
SaleCommon Shares | 700 | $128.71 | $90,093.99 |
DisclosureSEC source: 0000899243-21-029271 · doc4.xml · nonDerivative · entry 4 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 148,831 F1 · kind: The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · shares: These Securities are held of record by Versant Venture Management, LLC ("VVM LLC"), for the benefit of the Reporting Person, pursuant to an agreement between VVM LLC and the Reporting Person. F7 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $128.18 to $129.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (7) to this Form 4. F4 · ownership.nature: These securities are held of record by VVM LLC, a portion of which are held for the benefit of the Reporting Person, pursuant to an agreement between VVM LLC and the Reporting Person. The Reporting Person is a managing member of VVM LLC and the Reporting Person may be deemed to indirectly beneficially own the securities through his interest in VVM LLC. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 21:21 UTC |
Bolzon Bradley J PhDDirector
|
SaleCommon Shares | 1,324 | $127.36 | $168,619.34 |
DisclosureSEC source: 0000899243-21-029271 · doc4.xml · nonDerivative · entry 3 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 149,531 F1 · kind: The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · shares: These Securities are held of record by Versant Venture Management, LLC ("VVM LLC"), for the benefit of the Reporting Person, pursuant to an agreement between VVM LLC and the Reporting Person. F6 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $127.02 to $127.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (6) to this Form 4. F4 · ownership.nature: These securities are held of record by VVM LLC, a portion of which are held for the benefit of the Reporting Person, pursuant to an agreement between VVM LLC and the Reporting Person. The Reporting Person is a managing member of VVM LLC and the Reporting Person may be deemed to indirectly beneficially own the securities through his interest in VVM LLC. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 21:21 UTC |
Bolzon Bradley J PhDDirector
|
SaleCommon Shares | 4,472 | $126.41 | $565,288.97 |
DisclosureSEC source: 0000899243-21-029271 · doc4.xml · nonDerivative · entry 2 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 150,855 F1 · kind: The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · shares: These Securities are held of record by Versant Venture Management, LLC ("VVM LLC"), for the benefit of the Reporting Person, pursuant to an agreement between VVM LLC and the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $126.00 to $126.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (5) to this Form 4. F4 · ownership.nature: These securities are held of record by VVM LLC, a portion of which are held for the benefit of the Reporting Person, pursuant to an agreement between VVM LLC and the Reporting Person. The Reporting Person is a managing member of VVM LLC and the Reporting Person may be deemed to indirectly beneficially own the securities through his interest in VVM LLC. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 21:21 UTC |
Bolzon Bradley J PhDDirector
|
SaleCommon Shares | 3,504 | $125.67 | $440,345.23 |
DisclosureSEC source: 0000899243-21-029271 · doc4.xml · nonDerivative · entry 1 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 155,327 F1 · kind: The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · shares: These Securities are held of record by Versant Venture Management, LLC ("VVM LLC"), for the benefit of the Reporting Person, pursuant to an agreement between VVM LLC and the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $125.00 to $125.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. F4 · ownership.nature: These securities are held of record by VVM LLC, a portion of which are held for the benefit of the Reporting Person, pursuant to an agreement between VVM LLC and the Reporting Person. The Reporting Person is a managing member of VVM LLC and the Reporting Person may be deemed to indirectly beneficially own the securities through his interest in VVM LLC. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 21:43 UTC |
Novak RodgerDirector · President
|
SaleCommon Shares | 25,000 | $165.00 | $4,125,000.00 |
DisclosureSEC source: 0001209191-21-044516 · doc4.xml · nonDerivative · entry 1 Novak Rodger · CIK 0001682017 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 573,007 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| June 29, 2021 Filed Jun 30, 2021 22:41 UTC |
Bolzon Bradley J PhDDirector
|
SaleCommon Shares | 1,200 | $152.42 | $182,906.04 |
DisclosureSEC source: 0000899243-21-026801 · doc4.xml · nonDerivative · entry 25 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F27 · kind: The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F35 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $152.03 to $152.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (35) to this Form 4. Read SEC document |
| June 29, 2021 Filed Jun 30, 2021 22:41 UTC |
Bolzon Bradley J PhDDirector
|
SaleCommon Shares | 6,646 | $151.24 | $1,005,161.64 |
DisclosureSEC source: 0000899243-21-026801 · doc4.xml · nonDerivative · entry 24 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,200 F27 · kind: The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F34 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $151.00 to $151.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (34) to this Form 4. Read SEC document |
| June 29, 2021 Filed Jun 30, 2021 22:41 UTC |
Bolzon Bradley J PhDDirector
|
SaleCommon Shares | 12,753 | $150.49 | $1,919,237.23 |
DisclosureSEC source: 0000899243-21-026801 · doc4.xml · nonDerivative · entry 23 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,846 F27 · kind: The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F33 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $150.00 to $150.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (33) to this Form 4. Read SEC document |
| June 29, 2021 Filed Jun 30, 2021 22:41 UTC |
Bolzon Bradley J PhDDirector
|
SaleCommon Shares | 7,981 | $149.47 | $1,192,915.28 |
DisclosureSEC source: 0000899243-21-026801 · doc4.xml · nonDerivative · entry 22 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,599 F27 · kind: The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F32 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $149.00 to $149.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (32) to this Form 4. Read SEC document |
| June 29, 2021 Filed Jun 30, 2021 22:41 UTC |
Bolzon Bradley J PhDDirector
|
SaleCommon Shares | 12,176 | $148.58 | $1,809,095.47 |
DisclosureSEC source: 0000899243-21-026801 · doc4.xml · nonDerivative · entry 21 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,580 F27 · kind: The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F31 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $148.00 to $148.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (31) to this Form 4. Read SEC document |
| June 29, 2021 Filed Jun 30, 2021 22:41 UTC |
Bolzon Bradley J PhDDirector
|
SaleCommon Shares | 4,780 | $147.43 | $704,725.44 |
DisclosureSEC source: 0000899243-21-026801 · doc4.xml · nonDerivative · entry 20 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,756 F27 · kind: The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F30 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $147.01 to $147.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (30) to this Form 4. Read SEC document |
| June 29, 2021 Filed Jun 30, 2021 22:41 UTC |
Bolzon Bradley J PhDDirector
|
SaleCommon Shares | 600 | $146.69 | $88,015.98 |
DisclosureSEC source: 0000899243-21-026801 · doc4.xml · nonDerivative · entry 19 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,536 F27 · kind: The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F29 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $146.00 to $146.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (29) to this Form 4. Read SEC document |
| June 29, 2021 Filed Jun 30, 2021 22:41 UTC |
Bolzon Bradley J PhDDirector
|
SaleCommon Shares | 1,400 | $145.92 | $204,283.94 |
DisclosureSEC source: 0000899243-21-026801 · doc4.xml · nonDerivative · entry 18 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,136 F27 · kind: The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F28 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $145.89 to $145.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (28) to this Form 4. Read SEC document |
| June 28, 2021 Filed Jun 30, 2021 22:41 UTC |
Bolzon Bradley J PhDDirector
|
OtherCommon Shares | 847 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-026801 · doc4.xml · nonDerivative · entry 17 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,536 F26 · kind: Represents a change in the form of ownership of the Reporting Person by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VV V CAN. Read SEC document |
| June 28, 2021 Filed Jun 30, 2021 22:41 UTC |
Bolzon Bradley J PhDDirector
|
OtherCommon Shares | 6,018 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-026801 · doc4.xml · nonDerivative · entry 16 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F25 · kind: Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV V CAN to its partners. F24 · ownership.nature: Shares held by VV V CAN. VV V CAN GP is the sole general partner of VV V CAN. VV V CAN GP may be deemed to have voting and dispositive power over the securities held by VV V CAN and as a result may be deemed to have beneficial ownership over such securities. The Reporting Person is a director of VV V CAN GP and may be deemed to indirectly beneficially own the securities through his interest in VV V CAN GP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 28, 2021 Filed Jun 30, 2021 22:41 UTC |
Bolzon Bradley J PhDDirector
|
OtherCommon Shares | 6,018 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-026801 · doc4.xml · nonDerivative · entry 15 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 6,018 F23 · kind: Represents a change in the form of ownership of VV V CAN by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VVC CAN. F24 · ownership.nature: Shares held by VV V CAN. VV V CAN GP is the sole general partner of VV V CAN. VV V CAN GP may be deemed to have voting and dispositive power over the securities held by VV V CAN and as a result may be deemed to have beneficial ownership over such securities. The Reporting Person is a director of VV V CAN GP and may be deemed to indirectly beneficially own the securities through his interest in VV V CAN GP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 28, 2021 Filed Jun 30, 2021 22:41 UTC |
Bolzon Bradley J PhDDirector
|
OtherCommon Shares | 27,861 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-026801 · doc4.xml · nonDerivative · entry 14 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 16,434 F21 · kind: Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital V (Canada) LP ("VVC CAN") to its partners pursuant to a Rule 10b5-1 trading plan. F22 · ownership.nature: These securities are held of record by VVC CAN. Versant Ventures V GP-GP (Canada), Inc. ("VV V CAN GP") is the sole general partner of Versant Ventures V (Canada), L.P. ("VV V CAN") and VV V CAN is the sole general partner of VVC CAN. Each of VV V CAN GP and VV V CAN may be deemed to have voting and dispositive power over the securities held by VVC CAN and as a result may be deemed to have beneficial ownership over such securities. The Reporting Person is a director of VV V CAN GP and may be deemed to indirectly beneficially own the securities through his interest in VV V CAN GP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 28, 2021 Filed Jun 30, 2021 22:41 UTC |
Bolzon Bradley J PhDDirector
|
OtherCommon Shares | 18,973 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-026801 · doc4.xml · nonDerivative · entry 13 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,689 F20 · kind: Represents a change in the form of ownership of the Reporting Person by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VV V. Read SEC document |
| June 28, 2021 Filed Jun 30, 2021 22:41 UTC |
Bolzon Bradley J PhDDirector
|
OtherCommon Shares | 84,085 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-026801 · doc4.xml · nonDerivative · entry 12 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F19 · kind: Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV V to its members. F12 · ownership.nature: Shares held of record by VV V. The Reporting Person is a managing director of VV V and may be deemed to indirectly beneficially own the securities through his interest in VV V. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein, if any. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.